SOD1 and breast carcinoma: Consistent with this finding, LCS-1 has been reported to induce its anticancer effect through induction of mitochondrial superoxide and ROS in other cancers, including breast cancer [104], colorectal cancer [105,106], multiple myeloma [107], and glioma [108], which could be attributed to inhibition of SOD1.